Plus Therapeutics (PSTV) Misses Q2 EPS by 71c

Plus Therapeutics (NASDAQ: PSTV) reported Q2 EPS of ($0.71). Revenue for the quarter came in at $1.27 million.

For earnings history and earnings-related data on Plus Therapeutics (PSTV) click here.

You May Also Be Interested In

• Coherent posts a blowout Q4 and aggressive guidance, yet shares take a 5% haircut
• KLX Energy Services Holdings Inc. (KLXE) Tops Q2 EPS by 1539c
• Crown Crafts (CRWS) Reports Q1 EPS of $0.19